Fund shareholders of Celldex Therapeutics Inc
ISIN US15117B2025 · United States · LEI 529900F018DMYWH38923
- Fund shareholders
- 227
- Of which ETFs
- 44 183 other funds
- Value held
- 816.5M $ 7.8M SEK
- Share of capital
- 32.4 % of 78.5M shares on Jul 29, 2026
227 funds hold this company. This table lists the 226 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 826 | 26.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 792 | 23.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 778 | 23.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 777 | 24.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 753 | 24.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 753 | 24.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 629 | 20.7K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 453 | 14.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 413 | 13.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 358 | 11.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 325 | 10.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 312 | 10.3K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 262 | 8.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 253 | 8.3K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 245 | 8.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 219 | 6.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 166 | 5.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 150 | 4.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 138 | 4.5K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 137 | 4.5K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 125 | 4K $ | 0.80 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 90 | 2.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 67 | 2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 64 | 2K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 22 | 662 $ | 0.06 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 17 | 539.2 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 3.16 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2.07 % | as of Mar 31, 2026 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 1.34 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.29 % | as of Feb 28, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.17 % | as of Sep 30, 2025 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 1.02 % | as of Mar 31, 2026 ↗ |
| DWS Small Cap Growth Fund DEUTSCHE DWS INVESTMENT TRUST | 0.92 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.88 % | as of Apr 30, 2026 ↗ |
| DWS Small Mid Cap Growth VIP DEUTSCHE DWS VARIABLE SERIES II | 0.87 % | as of Mar 31, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 0.80 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 225 | +12 | 25,437,695 | -1.1 % |
| 2026Q1 | 213 | +1 | 25,733,608 | +2.1 % |
| 2025Q4 | 212 | +4 | 25,212,666 | +6.5 % |
| 2025Q3 | 208 | -2 | 23,671,171 | -17.4 % |
| 2025Q2 | 210 | +7 | 28,664,073 | -6.2 % |
| 2025Q1 | 203 | -19 | 30,569,939 | +1.6 % |
| 2024Q4 | 222 | +6 | 30,099,235 | +1.0 % |
| 2024Q3 | 216 | -12 | 29,799,647 | -1.0 % |
| 2024Q2 | 228 | +35 | 30,103,382 | +49.0 % |
| 2024Q1 | 193 | +1 | 20,205,896 | -1.6 % |
| 2023Q4 | 192 | 20,536,949 |
Institutional managers
218 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 8,560,476 | 271.5M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 5,840,567 | 185.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,369,885 | 170.3M $ | as of Mar 31, 2026 |
| FMR LLC | 3,749,048 | 118.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 3,229,939 | 102.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,804,168 | 88.9M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 2,696,616 | 85.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,086,332 | 66.2K $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 1,788,016 | 56.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,688,074 | 53.6M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,356,082 | 43M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,283,979 | 40.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,253,532 | 39.8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,224,165 | 38.8M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,200,000 | 38.1M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 1,200,000 | 38.1M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,059,534 | 33.6M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,037,000 | 32.9M $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 1,013,648 | 32.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 988,416 | 31.4M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 923,696 | 29.3M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 865,000 | 27.4M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 856,310 | 27.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 708,647 | 22.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 665,370 | 21.1M $ | as of Mar 31, 2026 |
Declared shareholders of Celldex Therapeutics Inc
There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Kynam Capital Management, LP and 2 others | 8.77 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 5.60 % | 3,749,048 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.17 % | 3,446,795 | as of Mar 31, 2026 · SCHEDULE 13G |
| STATE STREET CORPORATION | 4.20 % | 2,804,168 | as of Mar 31, 2026 · SCHEDULE 13G |
| Bellevue Group AG and 1 other | 1.50 % | 1,200,000 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Celldex Therapeutics Inc". https://titelia.com/en/stocks/celldex-therapeutics-inc-US15117B2025